We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+9.23%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$14.9B
AUM Growth
+$734M
(+5.2%)
Cap. Flow
-$271M
Cap. Flow
% of AUM
-1.83%
Top 10 Holdings %
Top 10 Hldgs %
17.52%
Holding
304
New
43
Increased
101
Reduced
105
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$215M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$184M |
| 3 |
Microsoft
MSFT
|
+$163M |
| 4 |
Biogen
BIIB
|
+$147M |
| 5 |
Synchrony
SYF
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$236M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$227M |
| 3 |
AbbVie
ABBV
|
+$169M |
| 4 |
Yum! Brands
YUM
|
+$147M |
| 5 |
Analog Devices
ADI
|
+$129M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.21% |
| 2 | Technology | 15.59% |
| 3 | Consumer Discretionary | 15.51% |
| 4 | Communication Services | 11.55% |
| 5 | Industrials | 11.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.89T
| $390M | 2.63% |
14,830,784
-1,126,680
| -7% | -$32.2M |
|
2
Jazz Pharmaceuticals
JAZZ
$15.9B
| $350M | 2.35% |
2,487,288
+188,562
| +8% | +$26.1M |
|
|
CELG
3
DELISTED
Celgene Corp
CELG
| $273M | 1.84% |
2,282,951
-113,869
| -5% | -$13.2M |
|
4
Teva Pharmaceuticals
TEVA
$35.9B
| $259M | 1.74% |
3,941,450
-1,613,980
| -29% | -$99.7M |
|
5
Meta Platforms (Facebook)
META
$1.51T
| $257M | 1.73% |
2,453,495
-145,259
| -6% | -$14.9M |
|
|
6
Alphabet (Google) Class A
GOOGL
$3.91T
| $226M | 1.52% |
+5,804,860
| New | +$215M |
|
7
Constellation Brands
STZ
$22.2B
| $226M | 1.52% |
1,583,351
-5,159
| -0.3% | -$710K |
|
|
8
Alphabet (Google) Class C
GOOG
$3.9T
| $221M | 1.48% |
5,814,300
-6,314,720
| -52% | -$227M |
|
|
9
Bristol-Myers Squibb
BMY
$127B
| $201M | 1.35% |
2,921,174
+2,790,844
| +2,141% | +$184M |
|
10
Visa
V
$677B
| $201M | 1.35% |
2,589,526
-151,977
| -6% | -$11.8M |
|
11
DuPont de Nemours
DD
$18.6B
| $198M | 1.33% |
1,515,375
+273,275
| +22% | +$35.1M |
|
12
United Airlines
UAL
$38.4B
| $197M | 1.33% |
3,444,077
+117,266
| +4% | +$6.77M |
|
13
Amazon
AMZN
$2.5T
| $195M | 1.31% |
5,760,460
+94,920
| +2% | +$2.99M |
|
14
Lowe's Companies
LOW
$116B
| $195M | 1.31% |
2,558,771
-88,522
| -3% | -$6.57M |
|
15
Steris
STE
$20.9B
| $191M | 1.29% |
2,537,159
-207,625
| -8% | -$15M |
|
|
16
Microsoft
MSFT
$2.84T
| $182M | 1.22% |
3,277,480
+3,101,887
| +1,767% | +$163M |
|
17
Palo Alto Networks
PANW
$264B
| $179M | 1.21% |
6,114,300
+443,550
| +8% | +$12.8M |
|
18
Comcast
CMCSA
$79.7B
| $178M | 1.2% |
6,313,542
-212,824
| -3% | -$6.41M |
|
19
Valero Energy
VLO
$89.8B
| $174M | 1.17% |
2,457,620
-140,417
| -5% | -$9.57M |
|
20
Home Depot
HD
$332B
| $170M | 1.15% |
1,289,071
-66,395
| -5% | -$8.45M |
|
21
Salesforce
CRM
$134B
| $170M | 1.14% |
2,162,363
-539,747
| -20% | -$42.1M |
|
22
Aptiv
APTV
$12B
| $159M | 1.07% |
1,848,963
-351,994
| -16% | -$29.4M |
|
|
23
Biogen
BIIB
$29.9B
| $157M | 1.06% |
513,667
+512,977
| +74,344% | +$147M |
|
24
Booking.com
BKNG
$138B
| $152M | 1.02% |
2,982,025
-806,725
| -21% | -$42.6M |
|
25
Coca-Cola Europacific Partners
CCEP
$46.5B
| $148M | 1% |
3,006,120
-109,321
| -4% | -$5.5M |
|
Similar funds
OAG
JG
CHP
SAM
Westfield Capital Management's Q4 2015 Portfolio in Review
As of Q4 2015, Westfield Capital Management held 304 positions worth $14.9B, up 5.2% from $14.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Westfield Capital Management's Q4 2015 filing shows 43 new, 101 increased, 105 reduced and 32 closed positions. Its largest new stake was Alphabet (Google) Class A: 5,804,860 shares worth $226M. The largest sale was Vertex Pharmaceuticals, an estimated $236M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
- Westfield Capital Management's largest Q4 2015 buy was Alphabet (Google) Class A: 5,804,860 shares worth $226M.
- Westfield Capital Management added most to Bristol-Myers Squibb in Q4 2015, an estimated $184M increase.
- Westfield Capital Management's biggest Q4 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $236M.
- Westfield Capital Management fully exited Analog Devices in Q4 2015, selling an estimated $129M.
- Westfield Capital Management's ten largest holdings make up 18% of its $14.9B portfolio in Q4 2015.
- Westfield Capital Management opened 43 new positions and closed 32 in Q4 2015.
- Westfield Capital Management's portfolio value rose 5.2% quarter-over-quarter to $14.9B.
Based on Westfield Capital Management's 13F filing for Q4 2015, filed 11 Feb 2016.